诊断专用酵素市场 - 产品（聚合酶和核酸酶、蛋白酶、氧化酶、糖酶）、应用（临床化学[血糖监测、POC 测试]、免疫测定、分子诊断） - 全球预测（2024 - 2032）

Diagnostic Specialty Enzymes Market - Product (Polymerases and Nucleases, Proteases, Oxidases, Carbohydrase), Application (Clinical Chemistry [Blood Glucose Monitoring, POC Testing], Immunoassay, Molecular Diagnostics) - Global Forecast (2024 - 2032)

出版日期: 2024年05月28日 | 出版商:

Global Market Insights Inc. | 英文 82 Pages | 商品交期: 2-3个工作天内

价格

简介目录

由于需要精确和早期检测的慢性和传染病日益流行，预计诊断专用酶市场规模从 2024 年到 2032 年将实现 8.1% 的复合年增长率。报告表明，全世界有三分之一的成年人患有多种慢性病。随着全球人口老化，癌症、糖尿病和心血管疾病等疾病的发病率不断上升，对能够提供准确、快速结果的先进诊断工具的需求不断增长。

分子诊断、个人化医疗和即时检测的创新也推动了对专用酵素的需求，以促进复杂的检测并提高诊断准确性。家庭检测的兴起以及对预防性医疗保健的日益关注也推动了市场的扩张。

诊断专用酵素产业分为产品、应用和区域。

就产品而言，氧化酶领域预计在 2024 年至 2032 年间大幅成长。氧化酶技术的进步提高了稳定性和反应特异性，加上对现场护理和家庭诊断解决方案不断增长的需求，将进一步促进该领域的成长。

在应用方面，由于其广泛应用于检测各种具有高特异性和敏感性的疾病和病症，到2032年，免疫分析领域的诊断特种酶市场将显着增长。免疫测定依赖于酶联免疫吸附测定 (ELISA) 和其他基于酶的检测方法，对于准确的疾病诊断和监测至关重要。

亚太地区诊断特种酵素产业预计将在 2024 年至 2032 年期间实现大幅扩张。对个人化医疗的关注和对早期疾病检测的日益重视也是推动区域产品采用的关键驱动力。

产业生态系统分析
产业影响力
- 成长动力
  - 分子诊断测试的成长
  - 对慢性病及时诊断的需求不断增加
  - 快速采用现场护理测试技术
  - 酵素生产技术的进展
- 产业陷阱与挑战
  - 严格的监管要求
  - 对产品品质和安全的担忧
成长潜力分析
未来市场趋势
监管环境
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司市占率分析
公司矩阵分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

主要趋势
聚合酶和核酸酶
蛋白酶
氧化酶
醣酶
其他产品

第 6 章：市场估计与预测：按应用分类，2021 - 2032

主要趋势
分子诊断
免疫分析
临床化学
- 血糖监测
- POC测试
- 其他临床化学测试
其他应用

第 7 章：市场估计与预测：按地区划分，2021 - 2032 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区

第 8 章：公司简介

Agilent Technologies, Inc.
Amano Enzymes Inc.
American Laboratories, Inc.
BBI Solutions
Biocatalysts Ltd. (BRAIN Biotech Group)
Bio-Rad Laboratories, Inc.
Codexis, Inc.
F. Hoffmann-La Roche Ltd.
Merck KGaA
New England Biolabs
Novozymes A/S
QIAGEN
SEKISUI Diagnostics
Takara Bio Inc.
Thermo Fisher Scientific Inc.

简介目录

Product Code: 9686

Diagnostic specialty enzymes market size is anticipated to observe an 8.1% CAGR from 2024 to 2032, driven by the increasing prevalence of chronic and infectious diseases that require precise and early detection. Reports indicate that 1 in 3 adults worldwide suffer from multiple chronic conditions. As the global population is aging and the incidence of diseases like cancer, diabetes, and cardiovascular conditions is rising, there is growing demand for advanced diagnostic tools that can provide accurate and rapid results.

Innovations in molecular diagnostics, personalized medicine, and point-of-care testing are also driving the demand for specialized enzymes to facilitate complex assays and improve diagnostic accuracy. The rise of home-based testing and the increasing focus on preventive healthcare are also driving the market expansion.

The diagnostic specialty enzymes industry is segmented into product, application, and region.

With respect to product, the oxidases segment is poised for substantial growth from 2024 to 2032. Oxidases play a pivotal role in a variety of high-precision diagnostic assays and biosensors, such as glucose monitoring in diabetes management as well as, detecting pathogens and metabolic disorders. Advancements in oxidase enzyme technology for enhancing stability and reaction specificity, coupled with the rising demand for point-of-care and home-based diagnostic solutions will further bolster the segment growth.

In terms of application, the diagnostic specialty enzymes market from the immunoassays segment will grow significantly through 2032 owing to its widespread application in detecting a variety of diseases and conditions with high specificity and sensitivity. Immunoassays, which rely on enzyme-linked immunosorbent assays (ELISA) and other enzyme-based detection methods, are crucial for accurate disease diagnosis and monitoring.

Asia Pacific diagnostic specialty enzymes industry is primed for significant expansion from 2024 to 2032. This growth is attributed to the increasing healthcare needs, the rising prevalence of chronic and infectious diseases, along with rapid advancements in diagnostic technologies. The focus on personalized medicine and the growing emphasis on early disease detection are also key drivers driving the regional product adoption.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growth in molecular diagnostic tests
  - 3.2.1.2 Increasing demand for timely diagnosis of chronic diseases
  - 3.2.1.3 Rapid adoption of point of care testing technologies
  - 3.2.1.4 Advances in enzyme production technology
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Stringent regulatory requirements
  - 3.2.2.2 Concerns related to product quality and safety
3.3 Growth potential analysis
3.4 Future market trends
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Polymerases and nucleases
5.3 Proteases
5.4 Oxidases
5.5 Carbohydrase
5.6 Other products

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Molecular diagnostics
6.3 Immunoassay
6.4 Clinical chemistry
- 6.4.1 Blood glucose monitoring
- 6.4.2 POC testing
- 6.4.3 Other clinical chemistry tests
6.5 Other applications

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Netherlands
- 7.3.7 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE
- 7.6.4 Rest of Middle East and Africa